News

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...
The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...
A recent CNBC interview with the OpenAI CEO shows that tech leaders are changing how they judge AI models.